Method for administering GLP-1 molecules

Details for Australian Patent Application No. 2003208945 (hide)

Owner Emisphere Technologies, Inc

Inventors Khan, Mohammed Amin

Agent Davies Collison Cave

Pub. Number AU-B-2003208945

PCT Number PCT/US03/03111

PCT Pub. Number WO2003/072195

Priority 60/358,184 20.02.02 US

Filing date 7 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 1 May 2008

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/20 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing sulfur

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/48 (2006.01) Drugs for disorders of the endocrine system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/358,184 20.02.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-B-2003208945

21 September 2006 Assignment before Grant

  Eli Lilly and Company The application has been assigned to Emisphere Technologies, Inc

1 May 2008 Application Accepted

  Published as AU-B-2003208945

28 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003208946-ANTI-INTERLEUKIN-1 BETA ANALOGS

2003208944-COMPUTER SYSTEMS AND METHODS FOR IDENTIFYING GENES AND DETERMINING PATHWAYS ASSOCIATED WITH TRAITS